Next 10 |
2024-04-11 15:56:04 ET Summary The FDA advisory committee voted 12-2 in favor of imetelstat's clinical profile in lower-risk myelodysplastic syndromes. The PDUFA target date for GERN's imetelstat NDA is June 16, 2024. An interim analysis in GERN's IMpactMF study in myelofibros...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following virtual investor conferences: 23 rd Annual Needham Virtual Health...
2024-03-19 09:21:13 ET More on Geron Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy Geron Post 2023 Earnings - Gearing Up For Critical Imetelstat AdCom, PDUFA Geron Corporation (GERN) Q4 2023 Earnings Call Transcript Geron surges a...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of an underwritten offering consisting of 41,999,998 shares of its common stock at a price of $3.00 per share and pre-funded warrants to purchase 8,002,668 shares of its common stock. Th...
2024-03-18 05:21:00 ET 3 Hot Tips for Choosing the Right Penny Stocks to Buy Navigating the realm of penny stocks can unlock pathways to significant financial growth, presenting a landscape ripe with opportunities for those astute enough to capitalize on them. Central to achieving succe...
2024-03-17 10:45:34 ET 3 Tips for Capitalizing on Market Cycles to Make Money With Penny Stocks Capitalizing on market cycles offers a strategic advantage in trading penny stocks, enabling investors to navigate through volatility and harness opportunities for significant returns. Unders...
2024-03-17 08:31:29 ET Friday saw an unprecedented surge in the stock of Geron Corporation (NASDAQ:GERN), with shares ending the day up a staggering 92%. This surge, marking a historic milestone for the company, was ignited by a momentous announcement earlier in the day. An FDA advi...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...
2024-03-15 12:52:05 ET More on Mid-day movers & stocks. Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Solidion Technology climbs 10% on $3.85M private placement Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M beats by $0.4M Financial i...
2024-03-15 12:42:01 ET DENVER, Colo., Mar 15, 2024 ( 247marketnews.com )- This morning’s notable listings with recent news include Verb Technology (NASDAQ: VERB ), Geron Corporation (NASDAQ: GERN ), Brera Holding ( NASDAQ:BREA ), Prairie Operating Co. (NASDAQ:PROP), a...
News, Short Squeeze, Breakout and More Instantly...
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday&r...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said "no" to MarineMax Inc (NYSE: HZO). "It's just too risky...
Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following virtual investor conferences: 23 rd Annual Needham Virtual Health...